All companies › WGS

WGS · GeneDx Holdings Corp.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells13
Research cases0
Last filing2026-09-16

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-01 — Feeley Kevin · sold 372 @ $83.84 2026-09-09 — Stueland Katherine · sold 3,692 @ $84.22 2026-09-09 — Feeley Kevin · sold 1,285 @ $84.22 2026-09-16 — Stueland Katherine · sold 148 @ $95.41 2026-09-16 — Stueland Katherine · sold 1,525 @ $96.90 2026-09-16 — Stueland Katherine · sold 1,648 @ $94.26 2026-09-16 — Stueland Katherine · sold 3,039 @ $99.00 2026-09-16 — Stueland Katherine · sold 4,141 @ $98.27 2026-09-16 — Feeley Kevin · sold 1,079 @ $99.00 2026-09-16 — Feeley Kevin · sold 1,470 @ $98.27 2026-09-16 — Feeley Kevin · sold 52 @ $95.41 2026-09-16 — Feeley Kevin · sold 541 @ $96.90 2026-09-16 — Feeley Kevin · sold 586 @ $94.26
2026-09-012026-09-16

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Feeley Kevin CHIEF FINANCIAL OFFICER
Stueland Katherine CHIEF EXECUTIVE OFFICER, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $WGS is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-16', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 148.0, 'price': 95.41, 'value': 14120.68, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 1525.0, 'price': 96.9, 'value': 147772.5, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 1648.0, 'price': 94.26, 'value': 155340.48, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 3039.0, 'price': 99.0, 'value': 300861.0, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 4141.0, 'price': 98.27, 'value': 406936.07, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 1079.0, 'price': 99.0, 'value': 106821.0, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 1470.0, 'price': 98.27, 'value': 144456.9, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 52.0, 'price': 95.41, 'value': 4961.32, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 541.0, 'price': 96.9, 'value': 52422.9, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 586.0, 'price': 94.26, 'value': 55236.36, 'is_buy': False}, {'transaction_date': '2026-09-09', 'insider_name': 'Stueland Katherine', 'insider_title': 'CHIEF EXECUTIVE OFFICER, Director', 'transaction_type': 'Open-market sell', 'shares': 3692.0, 'price': 84.22, 'value': 310940.24, 'is_buy': False}, {'transaction_date': '2026-09-09', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 1285.0, 'price': 84.22, 'value': 108222.7, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Feeley Kevin', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 372.0, 'price': 83.84, 'value': 31188.48, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for WGS today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.